News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘TranslationalResearch’ clear

  • The vaccine, which contained weakened poxviruses genetically programmed to spur an immune system attack on prostate tumor cells, helped patients lived longer than patients who received a placebo vaccine.

Tags: ProstateCancer, TranslationalResearch

  • Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Tags: Hormones, ProstateCancer, TranslationalResearch

  • A multi-institutional team of researchers has published a study that demonstrates a novel therapy works against solid tumors. It is the first targeted and programmed nanomedicine to enter human clinical studies.

Tags: TargetedTherapy, TranslationalResearch

  • Jessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.

Tags: Genomics, LungCancer, TargetedTherapy, TranslationalResearch

  • Belfer Institute and sanofi-aventis scientists will work jointly with the goal of discovering new anticancer drugs targeted at specific patient populations.

Tags: TargetedTherapy, TranslationalResearch

  • Two Dana-Farber researchers have been given an award for young investigators who are advancing the field of cancer research. Scott Armstrong, MD, PhD, is being recognized for achievements in cancer stem cell research and genomics; Kornelia Polyak, MD, PhD, for her pioneering discoveries in breast tissue.

Tags: BasicResearch, Honors, TranslationalResearch

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

  • The use of monoclonal antibodies to activate an immune-system response to abnormal cells resulted in a significant increase in survival time in patients with metastatic melanoma, report Dana-Farber researchers.

Tags: ImmuneSystem, Melanoma, TranslationalResearch

  • By conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.

Tags: LungCancer, TranslationalResearch

Showing 1-9 of 9 items